Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
Flavio De Maio, Brunella Posteraro, Francesca Romana Ponziani, Paola Cattani, Antonio Gasbarrini, Maurizio Sanguinetti
Abstract
We analyzed the bacterial communities of the nasopharynx in 40 SARS-CoV-2 infected and uninfected patients. All infected patients had a mild COVID-19 disease. We did not find statistically significant differences in either bacterial richness and diversity or composition. These findings suggest a nasopharyngeal microbiota at least early resilient to SARS-CoV-2 infection.
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)MicrobiomeMetagenomicsImmunology2019-20 coronavirus outbreakBiologyMedicineDiseaseVirologyMicrobiologyBioinformaticsInfectious disease (medical specialty)Internal medicineOutbreakGeneticsGeneRespiratory viral infections researchGut microbiota and healthPneumonia and Respiratory Infections